Clinical Trials, Mergers and Acquisitions, Research and Development
March 4, 2020
Via: FierceBiotechAlnylam Pharmaceuticals and Vir Biotechnology have teamed up to develop RNAi therapeutics against the coronavirus behind the COVID-19 outbreak. The collaboration builds on Alnylam synthesis of siRNAs that target highly conserved regions of coronavirus RNA. Vir and Alnylam joined forces […]
July 19, 2024
July 11, 2024
July 11, 2024